- Citations, last 5 years
- 455
- Works, last 5 years
- 35
- h-index
- 37
- Scientists listed
- 3
- Grants since 2016
- 8
Grants received
2021–2023 · research · R43
Selection of a lead candidate for the development of a novel anti-inflammatory therapeutic
Aleah Fox Caulin · Pear Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
A game-based intervention for Opioid Use Disorder
Hilary F Luderer · Pear Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R41
Application of TNFRSF25 agonists for prophylaxis and treatment of graft versus host disease
Matthew Seavey · Pear Therapeutics (United States) · funded by National Institutes of Health
2019–2022 · research · R44
A Prescription Digital Therapeutic to Promote Adherence to Buprenorphine Pharmacotherapy for Patients with Opioid Use Disorder
Hilary F Luderer · Pear Therapeutics (United States) · funded by National Institutes of Health
2017–2020 · research · R44
A game-based intervention for Opioid Use Disorder
Hilary F Luderer · Pear Therapeutics (United States) · funded by National Institutes of Health
2017–2018 · contract · N43
IGF::OT::IGF: Developing a Virtual Environment to Enhance Patient Engagement in Peer Support in Opioid Use Disorder. September 22, 2017 - March 21, 2018. N43DA-17-5586. Base Award
Ian Mcfarland · Pear Therapeutics (United States) · funded by National Institutes of Health
2017–2018 · research · R44
A game-based intervention for Opioid Use Disorder
Ian Mcfarland · Pear Therapeutics (United States) · funded by National Institutes of Health
2017–2022 · research · R44
A game-based intervention for Opioid Use Disorder
Hilary F Luderer · Pear Therapeutics (United States) · funded by National Institutes of Health